ClinicalTrials.gg
RecruitingNCT07768735Updated Nov 12, 2026

UNITY DX Cornea Study

An observational study in Tomography, sponsored by Alcon Research. Recruiting at 1 site in United States. Open to participants aged 22 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-12.

Sponsored by Alcon Research (part of Alcon) · Observational

From the registry’s dates

  • Started Sep 2026; still recruiting 1 month later.
Updated Nov 12, 2026Now RecruitingPrimary completion moved+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
110
Ages
22 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-18

Among 94 studies in Keratoconus with a site in United States — 27 open to participants now, 33 under way, 9 of them phase 3. Keratoconus · United States.

Planned enrollment
13th of 21
110 · median 168
Started
2026
with 4 others
Observational
22 of 94
10 open now
Primary completion
2026-12
later than 11 of 32 live
Registered
91st of 94
by date

Among the 94 studies in Keratoconus with a site in United States, this one is the 13th largest by planned enrollment of the 21 observational ones that give a count, is one of 5 that started in 2026, is one of 22 observational ones, reaches primary completion later than 11 of the 32 other live ones, and was the 91st registered.

Keratoconus

313 studies on the registry are indexed under Keratoconus; 56 are open to participants now.

Browse Keratoconus studies →

Open to participants now

27 of the 94 studies in Keratoconus with a site in United States are open now. Recruiting first, the newest first:

21 more — sign in →

All 27 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 37 Keratoconus studies recruiting now, 21 (57%) set no upper age limit and 11 (30%) stop at 75 or younger; 17 take children under 18; 15 take healthy volunteers.

This study: 22 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 94 studies in Keratoconus with a site in United States, or all of them as a file.
02

Study summary

The purpose of this study is to validate the clinical measurement performance of an investigational biometer. Subjects will undergo multiple measurements of the eye, and the agreement, repeatability, and reproducibility of corneal and epithelial thickness maps will be evaluated.

Read the detailed description

The study population will consist of male and female adult subjects with normal corneas (approximately 30 subjects), keratoconus (approximately 20 subjects), prior corneal laser vision correction (approximately 20 subjects), current and habitual contact lens wear (approximately 20 subjects), and dry eye (approximately 20 subjects). In this single visit study, measurements will be taken by 3 different operators using their own set of devices (configuration), UNITY DX and ANTERION. Each subject's participation is expected to last approximately 3 hours with a planned duration of exposure generally not longer than 10 minutes per device. Only one eye (designated as the study eye) will be enrolled per subject.

03

Conditions studied

  • Tomography

Keywords

  • Corneal surgery
  • Refractive surgery
  • Biometric parameters
  • Keratoconus
  • Dry eye
  • Laser vision correction
04

Who can participate

Ages eligible
22 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Cohorts will be selected from approximately one investigative site located in the United States.

Eligibility criteria

Key Inclusion Criteria:

  • Able to understand and sign an Institutional Review Board approved form.
  • Willing and able to attend all scheduled study visits as required per protocol.
  • Identified by the investigator as having normal corneas or abnormal corneas per protocol-specified criteria.
  • Other protocol-specified inclusion criteria may apply.

Key Exclusion Criteria:

  • Unable to fixate due to nystagmus or other eye movement abnormality, such as significant strabismus.
  • Any ocular disease and/or condition that, in the investigator's clinical judgement, may put the subject at significant risk, may compromise study results, or may interfere significantly with the subject's participation in the study.
  • Active ocular infection or inflammation.
  • Other protocol-specified exclusion criteria may apply.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
110 participants (estimated)
Patient registry
No

Groups and cohorts

  • Normal Corneas

    The eye will be imaged up to seven times with each biometer to achieve three acceptable scans. This cohort will enroll subjects with normal corneas.

    Device: UNITY DX · Device: ANTERION

  • Keratoconus

    The eye will be imaged up to seven times with each biometer to achieve three acceptable scans. This cohort will enroll subjects with keratoconus.

    Device: UNITY DX · Device: ANTERION

  • Prior Corneal Laser Vision Correction

    The eye will be imaged up to seven times with each biometer to achieve three acceptable scans. This cohort will enroll subjects with prior corneal laser vision correction.

    Device: UNITY DX · Device: ANTERION

  • Current and Habitual Contact Lens Wear

    The eye will be imaged up to seven times with each biometer to achieve three acceptable scans. This cohort will enroll subjects with current and habitual contact lens wear.

    Device: UNITY DX · Device: ANTERION

  • Dry Eye

    The eye will be imaged up to seven times with each biometer to achieve three acceptable scans. This cohort will enroll subjects with dry eye.

    Device: UNITY DX · Device: ANTERION

Interventions

  • DeviceUNITY DX

    Investigational non-contact, non-invasive ophthalmic imaging and analysis device used for visualization of ocular structures and their optical properties

  • DeviceANTERION

    Commercially available non-contact, non-invasive ophthalmic imaging and analysis device used for visualization of ocular structures and their optical properties

06

What researchers measure

Primary outcomes

  1. Mean corneal thickness

    Corneal thickness will be measured by the device and reported in microns. This outcome measure will be analyzed using Bland-Altman Limits of Agreement, Deming regression, repeatability and reproducibility.

    Time frame: Day 1

  2. Mean epithelial thickness

    Epithelial thickness will be measured by the device and reported in microns. This outcome measure will be analyzed using Bland-Altman Limits of Agreement, Deming regression, repeatability and reproducibility.

    Time frame: Day 1

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

3 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2026 (actual). Primary completion is estimated for Dec 2026, 3 months after the start.

Of 36 observational studies under Keratoconus, half reached primary completion within 30 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 95. This study's planned 3 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 12, 2026
First posted
Aug 17, 2026
StartActual
Sep 24, 2026
Primary completionEst.
Dec 2026
CompletionEst.
Dec 2026
Last update
Nov 12, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Oct 1, 2026
Sites
The Eye Institute of Utah is now Recruiting
Oct 1, 2026
Primary completion
Changed, then back to Dec 2026
moved 2 times, Oct 27, 2026 – Nov 12, 2026
Study completion
Changed, then back to Dec 2026
moved 2 times, Oct 27, 2026 – Nov 12, 2026
Show all 3 updates
  1. Nov 12, 2026
    Primary completion Nov 2026→Dec 2026
    Study completion Nov 2026→Dec 2026
    + 1 other change: verification date
  2. Oct 27, 2026
    Primary completion Dec 2026→Nov 2026
    Study completion Dec 2026→Nov 2026
    + 1 other change: verification date
  3. Oct 1, 2026
    Not yet recruiting→Recruiting
    The Eye Institute of Utah is now Recruiting
    + 2 other changes: verification date and date precision

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07768735
Lead sponsor
Alcon Research
Responsible party
Sponsor
First posted
Aug 17, 2026
Start date
Sep 24, 2026
Primary completion
Dec 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
Nov 12, 2026

Study contacts

Alcon Call Center
Contact
alcon.medinfo@alcon.com
1-888-451-3937
Clinical Trial Lead, Surgical
study director · Alcon Research, LLC

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion